JFG
HZNP

Jefferies Financial Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jefferies Financial Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-47,700
Closed -$5.52M – 2101
2023
Q3 		$5.52M Buy
+47,700
New +$5.13M 0.05% 309
2023
Q2 		– Sell
-6,275
Closed -$662K – 2131
2023
Q1 		$685K Buy
6,275
+1,403
+29% +$155K 0.01% 1008
2022
Q4 		$554K Buy
+4,872
New +$405K ﹤0.01% 1030

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jefferies Financial Group's HZNP Position: Q4 2023 in Review

Jefferies Financial Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 47,700 shares — an estimated $5.52M sold.

Jefferies Financial Group first reported a position in HZNP in Q4 2022 and held it in 3 quarters. The position peaked at $5.52M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Jefferies Financial Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 47,700 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $5.52M.
  • Jefferies Financial Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 3 quarters.
  • Jefferies Financial Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.52M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Jefferies Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.